Death of an antioxidant brings heart failure with preserved ejection fraction to life: 5-oxoproline and post-ischaemic cardio-renal dysfunction

Cardiovasc Res. 2018 Dec 1;114(14):1819-1821. doi: 10.1093/cvr/cvy239.

Authors

Joevin Sourdon¹, Gizem Keceli¹, Merry L Lindsey², Nazareno Paolocci^{1

3}

Affiliations

¹ Division of Cardiology, Johns Hopkins School of Medicine, Traylor 911, 720 Rutland Ave, Baltimore, MD, USA.
² Mississippi Center for Heart Research, University of Mississippi Medical Center, and Research Service, G.V. (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS, USA.
³ Department of Biomedical Sciences, University of Padua, Padua, Italy.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Animals
Antioxidants
Disease Models, Animal
Fibrosis
Heart Failure*
Kidney Diseases*
Mice
Oxidative Stress
Pyrrolidonecarboxylic Acid
Stroke Volume

Substances

Antioxidants
Pyrrolidonecarboxylic Acid

Grants and funding